miR-17-5p slows progression of hepatocellular carcinoma by downregulating TGFβR2.
Hao-Tian LiuCheng-Piao LuoMeng-Jie JiangZhu-Jian DengYu-Xian TengJia-Yong SuLi-Xin PanLiang MaPing-Ping GuoJian-Hong ZhongPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
The miRNA miR-17-5p can negatively regulate the expression of TGFβR2 and inhibit the EMT, thereby slowing tumor growth in HCC, suggesting a potential therapeutic approach against HCC.